Order

Hydrogen and health / Research review

Hydrogen and the liver: fatty liver and liver enzymes

Fatty liver is an area in which hydrogen inhalation was compared with placebo over 13 weeks. Lipids and liver enzymes improved, and in people with more severe fatty liver the fat content of the liver decreased.

Covers

  • fatty liver
  • liver enzymes
  • the liver during chemotherapy

Studies

Human studies: 4 studies in the cards below, including 3 randomised.

How hydrogen was given

Inhalation, hydrogen water.

On this page

The liver: key findings from the studies

  • Inhalation for 13 weeks (43 people): better lipids and liver enzymes than with placebo.
  • Hydrogen water for 28 days (12 people): less fat in the liver on magnetic resonance imaging.
  • Chemotherapy (136 people): liver enzymes rose in the placebo group but not in the hydrogen water group.

Hydrogen and non-alcoholic fatty liver disease

In a placebo-controlled study, 43 participants breathed a hydrogen-oxygen mixture for 13 weeks1. Lipids and liver enzymes improved. A reduction in fat content on ultrasound and CT was found in the subgroup with moderate or severe fatty liver.

In a crossover study, 12 people drank a litre of hydrogen water a day for 28 days and had less fat in selected areas of the liver on MRI than after placebo2. In another study in people with fatty liver, after 8 weeks of hydrogen water the level of coenzyme Q10 in blood platelets rose and the efficiency of their mitochondria improved3.

Hydrogen and the liver during chemotherapy

In 136 people receiving chemotherapy for colorectal cancer, liver enzymes rose in the placebo group but not in the hydrogen water group4.

Hydrogen and the liver: the studies we refer to

Click an entry to see who took part in the study, how hydrogen was given and what the result was.

What the studies say

Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.

1

Non-alcoholic fatty liver disease

randomised trialn = 43inhalation2022
Participants
People with NAFLD
Protocol
H2/O2 mixture for 13 weeks
Result
Improvement in lipids and liver enzymes; improvement in fat content on ultrasound/CT was found in the subgroup with moderate or severe NAFLD.
Study context
Randomised placebo-controlled study. Participants: 43.

Tao G i wsp.. A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease. Journal of cellular and molecular medicine 26(14): 4113-4123. 2022. PubMed 35734974 · DOI · Full text

2

Fatty liver assessed by MRI

Hydrogen waterrandomised trialn = 122019
Participants
People with overweight and mild/moderate NAFLD
Protocol
1 l/day for 28 days vs placebo
Result
MRI showed a lower fat content in selected areas of the liver after H2 than after placebo (p<0.05).
Study context
Pilot crossover RCT, double-blind. Participants: 12.

Korovljev D i wsp.. Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. Clinics and research in hepatology and gastroenterology 43(6): 688-693. 2019. PubMed 30982748 · DOI

3

Platelet bioenergetics in fatty liver

Hydrogen watercontrolled studyn = 302023
Participants
17 H2, 13 placebo; plus 15 healthy reference people
Protocol
3×330 ml/day, H2 >4 mg/l for 8 weeks
Result
After hydrogen, CoQ10 in platelets rose, TBARS fell and the efficiency of oxidative phosphorylation improved.
Study context
Placebo-controlled study. Participants: 30.

Sumbalová Z i wsp.. The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and Platelet Mitochondrial Bioenergetics in Patients with Non-Alcoholic Fatty Liver Disease. International journal of molecular sciences 24(15): 12477. 2023. PubMed 37569850 · DOI · Full text

4

Liver protection during chemotherapy for colorectal cancer

Hydrogen waterrandomised trialn = 1362017
Participants
144 randomised; final analysis: 76 H2 and 60 placebo
Protocol
H2 water as an addition to the mFOLFOX6 chemotherapy regimen
Result
After chemotherapy, ALT, AST and indirect bilirubin rose in the placebo group, while in the hydrogen group they stayed at a similar level. The authors described this as a signal of liver protection.
Study context
RCT, single-blind. Participants: 136.

Yang Q i wsp.. Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy. Molecular and clinical oncology 7(5): 891-896. 2017. PubMed 29142752 · DOI · Full text

Educational information, not medical advice. Full database of publications: Hydrogen Studies.

The liver: topics in this area

The liver and hydrogen: frequently asked questions

How was hydrogen given in the liver studies?

In the placebo-controlled study, participants inhaled a hydrogen-oxygen mixture for 13 weeks. In the others they drank hydrogen water: a litre a day for 28 days or three 330 ml servings for 8 weeks.

What changed after 13 weeks of inhalation in fatty liver?

Blood lipids and liver enzymes improved. In the subgroup with moderate or severe fatty liver, the fat content of the liver assessed by ultrasound and CT also fell.

Is it a medical device?

No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.

Is hydrogen inhalation safe?

In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.

See also